A comprehensive view of European Commission. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Wood & Building Products Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Commission approves Merck’s KEYTRUDA pembrolizumab plus chemotherapy as neoadjuvant treatment, then continued as monotherapy as adjuvant treatment, for resectable non-small cell lung cancer at high risk of recurrence in adults

European Commission plans expanded definition of 'advanced' biofuel, draws criticism from trade group EWABA, as changes would apply to aviation sector only; group says move disrupts fairness across sectors, undermines investments in biofuel supply chain

EU panel recommends approval of Novo Nordisk's weekly insulin therapy, Awiqli, based on successful Phase 3 clinical trials; European Commission decision awaited

Novartis AG gets positive opinion from CHMP for Fabhalta paroxysmal nocturnal hemoglobinuria treatment for adults; the therapy awaits final European Commission approval in the next two months, potentially becoming Europe's first oral monotherapy for PNH

Horizon Europe's PYSOLO project launches website; project seeks to combine concentrated solar power and biomass pyrolysis for decarbonizing chemical industry in EU

Ask us about our Wood & Building Products market view

Trending Chart

Interactive chart with headline count